Micah T. McClain, Ph.D. - Publications

Affiliations: 
2002 University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States 
Area:
Immunology, Pathology

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Steinbrink JM, Zaas AK, Betancourt M, Modliszewski JL, Corcoran DL, McClain MT. A transcriptional signature accurately identifies Aspergillus Infection across healthy and immunosuppressed states. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 32165060 DOI: 10.1016/J.Trsl.2020.02.005  0.314
2019 Lydon EC, Henao R, Burke TW, Aydin M, Nicholson BP, Glickman SW, Fowler VG, Quackenbush EB, Cairns CB, Kingsmore SF, Jaehne AK, Rivers EP, Langley RJ, Petzold E, Ko ER, ... McClain MT, et al. Validation of a host response test to distinguish bacterial and viral respiratory infection. Ebiomedicine. PMID 31631046 DOI: 10.1016/J.Ebiom.2019.09.040  0.31
2019 Jog NR, McClain MT, Heinlen LD, Gross T, Towner R, Guthridge JM, Axtell RC, Pardo G, Harley JB, James JA. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. Journal of Autoimmunity. 102332. PMID 31515129 DOI: 10.1016/J.Jaut.2019.102332  0.784
2019 Khan K, Betancourt-Quiroz M, Zaas AK, Treece AE, Que LG, Henao R, Suchindran S, McClain MT, Woods CW, Ginsburg GS, Tsalik EL, Tsalik EL. 2595. Murine Models for the Host Response to Typical and Atypical Pneumonia Open Forum Infectious Diseases. 6: S902-S902. DOI: 10.1093/Ofid/Ofz360.2273  0.34
2019 Steinbrink JM, Zaas AK, Βncourt-Quiroz M, Modliszewski JL, Corcoran D, McClain MT. 1721. A Transcriptional Signature of Acute Aspergillus Infection Offers High Diagnostic Accuracy Despite the Presence of Immunosuppression Open Forum Infectious Diseases. 6: S630-S631. DOI: 10.1093/Ofid/Ofz360.1584  0.317
2019 Steinbrink JM, Hua K, Myers R, Johnson MD, Seidelman J, Tsalik EL, Tsalik EL, Alexander BD, McClain MT. 2885. A Host Transcriptional Signature for Accurate Diagnosis of Candidemia in the Hospital Setting Open Forum Infectious Diseases. 6: S76-S76. DOI: 10.1093/Ofid/Ofz359.163  0.344
2018 Fourati S, Talla A, Mahmoudian M, Burkhart JG, Klén R, Henao R, Yu T, Aydın Z, Yeung KY, Ahsen ME, Almugbel R, Jahandideh S, Liang X, Nordling TEM, Shiga M, ... ... McClain MT, et al. A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infection. Nature Communications. 9: 4418. PMID 30356117 DOI: 10.1038/S41467-018-06735-8  0.3
2017 Burke TW, Henao R, Soderblom E, Tsalik EL, Thompson JW, McClain MT, Nichols M, Nicholson BP, Veldman T, Lucas JE, Moseley MA, Turner RB, Lambkin-Williams R, Hero AO, Woods CW, et al. Nasopharyngeal Protein Biomarkers of Acute Respiratory Virus Infection. Ebiomedicine. PMID 28238698 DOI: 10.1016/J.Ebiom.2017.02.015  0.327
2016 Holcomb ZE, Tsalik EL, Woods CW, McClain MT. Host-based Peripheral Blood Gene Expression Analysis for the Diagnosis of Infectious Diseases. Journal of Clinical Microbiology. PMID 27795332 DOI: 10.1128/Jcm.01057-16  0.316
2016 McClain MT, Nicholson BP, Park LP, Liu TY, Hero AO, Tsalik EL, Zaas AK, Veldman T, Hudson LL, Lambkin-Williams R, Gilbert A, Burke T, Nichols M, Ginsburg GS, Woods CW. A Genomic Signature of Influenza Infection Shows Potential for Presymptomatic Detection, Guiding Early Therapy, and Monitoring Clinical Responses. Open Forum Infectious Diseases. 3: ofw007. PMID 26933666 DOI: 10.1093/Ofid/Ofw007  0.333
2016 Tsalik EL, Henao R, Nichols M, Burke T, Ko ER, McClain MT, Hudson LL, Mazur A, Freeman DH, Veldman T, Langley RJ, Quackenbush EB, Glickman SW, Cairns CB, Jaehne AK, et al. Host gene expression classifiers diagnose acute respiratory illness etiology. Science Translational Medicine. 8: 322ra11. PMID 26791949 DOI: 10.1126/Scitranslmed.Aad6873  0.311
2015 Tsalik EL, Li Y, Hudson LL, Chu VH, Himmel T, Limkakeng AT, Katz JN, Glickman SW, McClain MT, Welty-Wolf KE, Fowler VG, Ginsburg GS, Woods CW, Reed SD. Potential Cost-effectiveness of Early Identification of Hospital-acquired Infection in Critically Ill Patients. Annals of the American Thoracic Society. PMID 26700878 DOI: 10.1513/Annalsats.201504-205Oc  0.301
2015 McClain MT, Henao R, Williams J, Nicholson B, Veldman T, Hudson L, Tsalik EL, Lambkin-Williams R, Gilbert A, Mann A, Ginsburg GS, Woods CW. Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge. Clinical and Experimental Immunology. PMID 26506932 DOI: 10.1111/Cei.12736  0.316
2015 Ko ER, Yang WE, McClain MT, Woods CW, Ginsburg GS, Tsalik EL. What was old is new again: using the host response to diagnose infectious disease. Expert Review of Molecular Diagnostics. 1-16. PMID 26145249 DOI: 10.1586/14737159.2015.1059278  0.308
2014 Tsalik EL, Langley RJ, Dinwiddie DL, Miller NA, Yoo B, van Velkinburgh JC, Smith LD, Thiffault I, Jaehne AK, Valente AM, Henao R, Yuan X, Glickman SW, Rice BJ, McClain MT, et al. An integrated transcriptome and expressed variant analysis of sepsis survival and death. Genome Medicine. 6: 111. PMID 25538794 DOI: 10.1186/S13073-014-0111-5  0.318
2013 McClain MT, Park LP, Nicholson B, Veldman T, Zaas AK, Turner R, Lambkin-Williams R, Gilbert AS, Ginsburg GS, Woods CW. Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 58: 689-95. PMID 24140015 DOI: 10.1016/J.Jcv.2013.09.015  0.329
2013 Zaas AK, Burke T, Chen M, McClain M, Nicholson B, Veldman T, Tsalik EL, Fowler V, Rivers EP, Otero R, Kingsmore SF, Voora D, Lucas J, Hero AO, Carin L, et al. A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. Science Translational Medicine. 5: 203ra126. PMID 24048524 DOI: 10.1126/Scitranslmed.3006280  0.303
2013 Bagga B, Woods CW, Veldman TH, Gilbert A, Mann A, Balaratnam G, Lambkin-Williams R, Oxford JS, McClain MT, Wilkinson T, Nicholson BP, Ginsburg GS, Devincenzo JP. Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals. Antiviral Therapy. 18: 785-91. PMID 23714753 DOI: 10.3851/Imp2629  0.305
2013 Woods CW, McClain MT, Chen M, Zaas AK, Nicholson BP, Varkey J, Veldman T, Kingsmore SF, Huang Y, Lambkin-Williams R, Gilbert AG, Hero AO, Ramsburg E, Glickman S, Lucas JE, et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. Plos One. 8: e52198. PMID 23326326 DOI: 10.1371/Journal.Pone.0052198  0.307
2011 Moody MA, Zhang R, Walter EB, Woods CW, Ginsburg GS, McClain MT, Denny TN, Chen X, Munshaw S, Marshall DJ, Whitesides JF, Drinker MS, Amos JD, Gurley TC, Eudailey JA, et al. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. Plos One. 6: e25797. PMID 22039424 DOI: 10.1371/Journal.Pone.0025797  0.352
2011 Huang Y, Zaas AK, Rao A, Dobigeon N, Woolf PJ, Veldman T, Øien NC, McClain MT, Varkey JB, Nicholson B, Carin L, Kingsmore S, Woods CW, Ginsburg GS, Hero AO. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. Plos Genetics. 7: e1002234. PMID 21901105 DOI: 10.1371/Journal.Pgen.1002234  0.335
2010 Heinlen LD, Ritterhouse LL, McClain MT, Keith MP, Neas BR, Harley JB, James JA. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. Journal of Molecular Medicine (Berlin, Germany). 88: 719-27. PMID 20396862 DOI: 10.1007/S00109-010-0618-1  0.772
2010 Heinlen LD, McClain MT, Ritterhouse LL, Bruner BF, Edgerton CC, Keith MP, James JA, Harley JB. 60 kD Ro and nRNP A frequently initiate human lupus autoimmunity. Plos One. 5: e9599. PMID 20224770 DOI: 10.1371/Journal.Pone.0009599  0.745
2007 James JA, Kim-Howard XR, Bruner BF, Jonsson MK, McClain MT, Arbuckle MR, Walker C, Dennis GJ, Merrill JT, Harley JB. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus. 16: 401-9. PMID 17664230 DOI: 10.1177/0961203307078579  0.78
2007 Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, James JA. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis and Rheumatism. 56: 2344-51. PMID 17599763 DOI: 10.1002/Art.22665  0.787
2007 Heinlen L, McClain M, Prestigiacomo T, Bruner B, Binder S, Edgerton C, Rubertone M, James J, Harley J. Autoantibody Onset Prior to SLE Diagnosis Follows Predictable Patterns of Development Clinical Immunology. 123: S101. DOI: 10.1016/J.Clim.2007.03.467  0.761
2006 McClain MT, Poole BD, Bruner BF, Kaufman KM, Harley JB, James JA. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis and Rheumatism. 54: 360-8. PMID 16385527 DOI: 10.1002/Art.21682  0.783
2006 Heinlen L, McClain M, Pachner A, Harley J, James J. Sa.16. Multiple Sclerosis Patients Exhibit a Unique Humoral Response to the Epstein-Barr Virus Nuclear Antigen-1 Clinical Immunology. 119: S110. DOI: 10.1016/J.Clim.2006.04.248  0.778
2006 Heinlen L, McClain M, Miner J, Scofield H, Harley J, James J. F.66. SLE Patient Anti-Ro 169 Antibodies Are Associated with Leucopenia and Bind the Surface of Neutrophils Clinical Immunology. 119: S74. DOI: 10.1016/J.Clim.2006.04.106  0.776
2005 Scofield RH, Kurien BT, Ganick S, McClain MT, Pye Q, James JA, Schneider RI, Broyles RH, Bachmann M, Hensley K. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radical Biology & Medicine. 38: 719-28. PMID 15721982 DOI: 10.1016/J.Freeradbiomed.2004.11.001  0.578
2005 McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nature Medicine. 11: 85-9. PMID 15619631 DOI: 10.1038/Nm1167  0.814
2004 McClain MT, Arbuckle MR, Heinlen LD, Dennis GJ, Roebuck J, Rubertone MV, Harley JB, James JA. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis and Rheumatism. 50: 1226-32. PMID 15077305 DOI: 10.1002/Art.20120  0.803
2004 McClain MT, Lutz CS, Kaufman KM, Faig OZ, Gross TF, James JA. Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response. Proceedings of the National Academy of Sciences of the United States of America. 101: 3551-6. PMID 14988508 DOI: 10.1073/Pnas.0306267101  0.531
2004 Kelleher P, James JA, McClain MT, Arbuckle MR, Harley JB. Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus [3] (multiple letters) New England Journal of Medicine. 350: 305. PMID 14724314 DOI: 10.1056/NEJM200401153500320  0.321
2004 Harley JB, Kelly JA, McClain MT, James JA. 9 THE GENES, ENVIRONMENT, AND HOST IMMUNE RESPONSES IN THE ETIOLOGY OF SYSTEMIC LUPUS ERYTHEMATOSUS. Journal of Investigative Medicine. 52: S258.4-S258. DOI: 10.1136/Jim-52-Suppl1-562  0.533
2003 Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England Journal of Medicine. 349: 1526-33. PMID 14561795 DOI: 10.1056/Nejmoa021933  0.592
2003 Heinlen LD, McClain MT, Kim X, Quintero DR, James JA, Harley JB, Scofield RH. Anti-Ro and anti-nRNP response in unaffected family members of SLE patients. Lupus. 12: 335-7. PMID 12729062 DOI: 10.1191/0961203303lu377xx  0.767
2003 McClain MT, Rapp EC, Harley JB, James JA. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. Journal of Medical Virology. 70: 253-7. PMID 12696112 DOI: 10.1002/Jmv.10385  0.614
2003 Arbuckle MR, James JA, Dennis GJ, Rubertone MV, McClain MT, Kim XR, Harley JB. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus. 12: 99-106. PMID 12630753 DOI: 10.1191/0961203303Lu334Oa  0.553
2002 McClain MT, Scofield RH, Kurien BT, Gross TF, James JA. Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE. Scandinavian Journal of Immunology. 56: 399-407. PMID 12234261 DOI: 10.1046/J.1365-3083.2002.01141.X  0.587
2002 Lutz CS, McClain MT, Harley JB, James JA. Anti-U1A monoclonal antibodies recognize unique epitope targets of U1A which are involved in the binding of U1 RNA. Journal of Molecular Recognition : Jmr. 15: 163-70. PMID 12203842 DOI: 10.1002/Jmr.569  0.525
2002 McClain MT, Ramsland PA, Kaufman KM, James JA. Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. Journal of Immunology (Baltimore, Md. : 1950). 168: 2054-62. PMID 11823543 DOI: 10.4049/Jimmunol.168.4.2054  0.491
2001 McClain MT, Harley JB, James JA. The role of Epstein-Barr virus in systemic lupus erythematosus. Frontiers in Bioscience : a Journal and Virtual Library. 6: E137-47. PMID 11578968  0.538
2001 Kaufman KM, Kirby MY, McClain MT, Harley JB, James JA. Lupus autoantibodies recognize the product of an alternative open reading frame of SmB/B'. Biochemical and Biophysical Research Communications. 285: 1206-12. PMID 11478783 DOI: 10.1006/Bbrc.2001.5302  0.57
1999 James JA, McClain MT, Koelsch G, Williams DG, Harley JB. Side-chain specificities and molecular modelling of peptide determinants for two anti-Sm B/B' autoantibodies. Journal of Autoimmunity. 12: 43-9. PMID 10028021 DOI: 10.1006/Jaut.1998.0252  0.513
Show low-probability matches.